Schultz, Anna Reister
Oregon Health & Science University · OHSU Knight Cancer Institute
3 papers on CoChatORCID 0000-0001-9977-7343
Most cited papers
- Verified
Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia
Bottomly, D., Long, N., Schultz, A. R., Kurtz, S. E., Tognon, C. E., Johnson, K., Abel, M., Agarwal, A., Avaylon, S., Benton, E., et al. (2022) · Cancer Cell
Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes
Cited by 403
- Verified
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
Eide, C. A., Zabriskie, M. S., Savage Stevens, S. L., Antelope, O., Vellore, N. A., Than, H., Schultz, A. R., Clair, P., Bowler, A. D., Pomicter, A. D., et al. (2019) · Cancer Cell
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 247
- Verified
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
Burslem, G. M., Schultz, A. R., Bondeson, D. P., Eide, C. A., Savage Stevens, S. L., Druker, B. J., & Crews, C. M. (2019) · Cancer Research
Protein Degradation and InhibitorsChronic Myeloid Leukemia Treatments
Cited by 212
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free